These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 27874961)

  • 41. MicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cells.
    Zhu Z; Xu T; Wang L; Wang X; Zhong S; Xu C; Shen Z
    FEBS Lett; 2014 Aug; 588(17):3180-5. PubMed ID: 24999188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. NTRK2 is an oncogene and associated with microRNA-22 regulation in human gastric cancer cell lines.
    Hu J; Huang Y; Wu Y; Liu F; Sun D; Wang K; Qu H
    Tumour Biol; 2016 Nov; 37(11):15115-15123. PubMed ID: 27662840
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MiR-205 serves as a prognostic factor and suppresses proliferation and invasion by targeting insulin-like growth factor receptor 1 in human cervical cancer.
    Pang H; Yue X
    Tumour Biol; 2017 Jun; 39(6):1010428317701308. PubMed ID: 28651495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-519d-3p Inhibits Cell Proliferation and Invasion of Gastric Cancer by Downregulating B-Cell Lymphoma 6.
    Li YY; Shao JP; Zhang SP; Xing GQ; Liu HJ
    Cytogenet Genome Res; 2018; 154(1):12-19. PubMed ID: 29510377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion.
    Chen JJ; Cai WY; Liu XW; Luo QC; Chen G; Huang WF; Li N; Cai JC
    PLoS One; 2015; 10(5):e0126890. PubMed ID: 26010149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
    Li Z; Yu X; Wang Y; Shen J; Wu WK; Liang J; Feng F
    Oncotarget; 2015 Jul; 6(19):17559-69. PubMed ID: 25654811
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoxia-induced miR-214 expression promotes tumour cell proliferation and migration by enhancing the Warburg effect in gastric carcinoma cells.
    Yang L; Zhang W; Wang Y; Zou T; Zhang B; Xu Y; Pang T; Hu Q; Chen M; Wang L; Lv Y; Yin K; Liang H; Chen X; Xu G; Zou X
    Cancer Lett; 2018 Feb; 414():44-56. PubMed ID: 29129783
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β.
    Wang H; Yan X; Ji LY; Ji XT; Wang P; Guo SW; Li SZ
    Technol Cancer Res Treat; 2017 Aug; 16(4):497-511. PubMed ID: 26868851
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer.
    Zhang Q; Feng Y; Liu P; Yang J
    Tumour Biol; 2017 Jul; 39(7):1010428317711312. PubMed ID: 28718369
    [TBL] [Abstract][Full Text] [Related]  

  • 50. miR-21 Inhibitors Modulate Biological Functions of Gastric Cancer Cells via PTEN/PI3K/mTOR Pathway.
    Wang P; Guan Q; Zhou D; Yu Z; Song Y; Qiu W
    DNA Cell Biol; 2018 Jan; 37(1):38-45. PubMed ID: 29185784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letter to the Editor: Estrogen and Medulloblastoma.
    Gallo D; Ciucci A; Mancuso M
    Endocrinology; 2015 Aug; 156(8):L6-7. PubMed ID: 26186162
    [No Abstract]   [Full Text] [Related]  

  • 52. Reply - Letter to the Editor - Statistically but not clinically significant? Biomarkers in gastric cancer.
    Mocellin MC; de Moraes Trindade EBS
    Clin Nutr; 2018 Dec; 37(6 Pt A):2289-2290. PubMed ID: 30201142
    [No Abstract]   [Full Text] [Related]  

  • 53. Reply to the letter to the editor: concerns regarding the additional value of hematocrit-based extracellular volume fraction for characterization of gastric cancer.
    Nishimuta Y; Tsurumaru D
    Jpn J Radiol; 2023 Dec; 41(12):1432. PubMed ID: 37477818
    [No Abstract]   [Full Text] [Related]  

  • 54. A potential new player in gastric cancer.
    Taglialegna A
    Nat Rev Microbiol; 2024 Apr; 22(4):188. PubMed ID: 38383798
    [No Abstract]   [Full Text] [Related]  

  • 55. Cancer Progress and Priorities: Gastric Cancer-Letter.
    Tavakkoli A; Pruitt SL; Murphy CC
    Cancer Epidemiol Biomarkers Prev; 2023 Sep; 32(9):1270. PubMed ID: 37655426
    [No Abstract]   [Full Text] [Related]  

  • 56. Letter to the Editor: LO2, a misidentified cell line: Some data should be interpreted with caution.
    Weiskirchen R
    Hepatology; 2023 Apr; 77(4):E66. PubMed ID: 36040018
    [No Abstract]   [Full Text] [Related]  

  • 57. MicroRNAs in Human Disease: Commentary.
    M Adcock I; Mumby S
    Iran J Allergy Asthma Immunol; 2021 Jun; 20(3):259-262. PubMed ID: 34134446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Letter to the Editor: The Limited Functions and Mechanisms of CircASAP1 as a Sponge of Onco-microRNAs.
    Wang YZ
    Hepatology; 2021 Jun; 73(6):2610. PubMed ID: 33107137
    [No Abstract]   [Full Text] [Related]  

  • 59. Letter to the Editor - miR-494 inhibits invasion and proliferation of gastric cancer by targeting IGF-1R.
    Cavaliere C; D'Aniello C; Cerillo I; Facchini G
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(21):4409-4410. PubMed ID: 27874961
    [No Abstract]   [Full Text] [Related]  

  • 60. Silencing insulin-like growth factor-1 receptor expression inhibits gastric cancer cell proliferation and invasion.
    Ge J; Chen Z; Huang J; Yuan W; Den Z; Chen Z
    Mol Med Rep; 2015 Jan; 11(1):633-8. PubMed ID: 25339573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.